Wall Street is backing a new class of psychedelic drugs. (60 minutes also had a segment on the medical benefits of this topic)
WSJ News Exclusive | Wall Street Backs New Class of Psychedelic Drugs
The psychedelic-therapy industry is getting a reality trip as investors and startups focus on treatments that will cost less time and money.
www.wsj.com